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Abstract
We assessed the cardiorespiratory and immune response to physical exertion following secondhand smoke (SHS) exposure
through a randomized crossover experiment. Data were obtained from 16 (8 women) non-smoking adults during and
following a maximal oxygen uptake cycling protocol administered at baseline and at 0-, 1-, and 3- hours following 1-hour of
SHS set at bar/restaurant carbon monoxide levels. We found that SHS was associated with a 12% decrease in maximum power
output, an 8.2% reduction in maximal oxygen consumption, a 6% increase in perceived exertion, and a 6.7% decrease in time
to exhaustion (P,0.05). Moreover, at 0-hours almost all respiratory and immune variables measured were adversely affected
(P,0.05). For instance, FEV1 values at 0-hours dropped by 17.4%, while TNF-a increased by 90.1% (P,0.05). At 3-hours mean
values of cotinine, perceived exertion and recovery systolic blood pressure in both sexes, IL4, TNF-a and IFN-c in men, as well
as FEV1/FVC, percent predicted FEV1, respiratory rate, and tidal volume in women remained different compared to baseline
(P,0.05). It is concluded that a 1-hour of SHS at bar/restaurant levels adversely affects the cardiorespiratory and immune
response to maximal physical exertion in healthy nonsmokers for at least three hours following SHS.
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Introduction
Thirty years after the publication of the first evidence regarding the
unfavorable health effects of secondhand smoke (SHS) exposure [1] more
than half of American, European and Chinese adult nonsmokers suffer
daily SHS as the prevalence rates of smoking continue to rise across the
globe [2]. Moreover, current estimates suggest that 80% of American and
76% of European teenagers are regularly exposed to SHS [3,4]. Major
chronic diseases are generally the result of long-term processes, yet recent
data by our group [5,6,7,8] and others [9,10,11] show that even brief
SHS exposures appear to initiate mechanisms that contribute to disease
pathogenesis. For instance, shortly after being exposed to SHS there is a
marked increase in interleukin (IL) 1 beta [6,12], IL4, tumor necrosis
factor alpha (TNF-a) [12], white blood cell count, C-reactive protein,
homocysteine,fibrinogen [11] aswell asleukocyte countsaccompanied by
an immune cell activation [13]. Interestingly, the observed inflammatory
reactions persist for at least 3 hours following SHS exposure [12] and
a p p e a r st ob em o r ep o t e n ti nm e nc o m p a r e dt ow o m e n[ 6 , 1 2 ] .
The SHS-induced immune response raises concerns for potentially
intensified system disruption when additional strains are added such as
physical exertion, especially in individuals with (or at risk for)
cardiovascular disease, chronic lung disease or allergies. Indeed, it is
not uncommon for individuals to suffer SHS at home or at the
workplace and subsequently to exert significant physical effort, such as
walk fast for several minutes or climb a few sets of stairs while carrying
heavy objects. For instance, blue-collar workers (e.g., construction
labors, factory workers, freight handlers, assemblers, mechanics) that
are constantly active, reaching high energy expenditures (e.g., an 86-kg
individual tending a furnace in a steel mill utilizes on average
648 kcal?h
21) [14], are more likely to be exposed to workplace SHS
compared to white-collar workers [15,16,17].
Understanding the acute and short-term effects of SHS on the
cardiorespiratory and immune response to physical exertion is essential
because the physical and metabolic adaptations involved can increase
the risk of acute coronary complications and life-threatening myocardial
ischemia even in apparently healthy individuals [18,19]. Therefore, we
conducted a randomized single-blind crossover experiment to assess the
cardiorespiratory and immune response to maximal physical exertion
prior to as well as 0, 1, and 3 hours following 1-hour of moderate SHS.
Materials and Methods
Ethics Statement
The study was conducted according to the principles expressed
in the Declaration of Helsinki and was approved by the University
of Thessaly Ethics Review Board.
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Recruitment was conducted through newspaper and radio
announcements, wall posters, as well as word of mouth. Exclusion
criteria (assessed via medical history) included: smoking, pregnan-
cy, evidence of cardiac or pulmonary disease, and previous disease
or medications known to affect lung function. All women
participants were premenopausal with regular menstruation and
were tested during the late luteal phase of their menstrual cycle.
All participants were given a detailed verbal description of the
protocol, followed by extensive familiarization with all data
collection procedures and instruments during a familiarization
visit performed .5 days prior to testing. The experimental
protocol is illustrated in Figure 1. To eliminate the effect of
cotinine’s comparatively long half-life (i.e., approx. 20 hours [20]),
the study adopted a randomized crossover design with participants
visiting the laboratory on four different occasions, separated by $7
days, where they underwent four different trials in a random order
through a random allocation algorithm (PASW Statistics 18, SPSS
Inc., Chicago, USA). Furthermore, in order to eliminate the effect
of diurnal variation, all data were collected at the same time of the
day. Participants arrived in the laboratory at 0730 h for every trial.
During the baseline trial participants underwent a physical
exertion bout that started at 1200 h without any SHS. In the
remaining trials, one hour of SHS was administered either at
0800 h, or at 1000 h or at 1100 h, while the same physical
exertion protocol initiated always at 1200 h. This design enabled
data collection in response to maximal physical exertion without
SHS (TB) as well as immediately following (T0), at one hour after
(T1) and at three hours after SHS (T3), with the data being
collected at the same time of the day and without the effect of
previous or subsequent physical exertion since only one assessment
was conducted per trial. Five minutes following the end of physical
exertion (passive recovery with participants lying in semi-supine
position), heart rate, arterial blood pressure, cotinine, lung
function and cytokine levels were evaluated as described below.
Measurements of the targeted variables were conducted using
identical pre-calibrated equipment in a quiet room maintained at
22–25uC air temperature. The same room was used for the
participants to remain at rest before or after SHS and until the
initiation of physical exertion. For all trials, caloric intake was
restricted while ad libitum water consumption was permitted. All
participants arrived at the laboratory following a 10-hour fast, and
were instructed to refrain from strenuous physical exertion and
other excessive stressors for 72 h prior to each trial. All testing was
conducted by the same trained investigators, who were unaware of
the specific trial that each participant was undergoing. To ensure
that the investigators would not be able to differentiate between
trials, all participants were given a shirt and athletic pants to wear
upon exiting the chamber following all exposure trials and prior to
the physical exertion bout in the baseline trial. These clothes had
been previously exposed to tobacco smoke and emitted strong
tobacco scent. Moreover, since the physical exertion protocol was
conducted always at 1200 h (with SHS at 0800 h, or at 1000 h or
at 1100 h), it was not possible for the investigators collecting the
data to know which trial a subject was undergoing.
Secondhand Smoke (SHS). During T0, T1 and T3,
participants remained seated at rest for 1 hour inside a
66564 m environmentally controlled chamber (air temperature:
24uC; air velocity: 0.05 mNs
21; humidity: 45%). The SHS was
adjusted at a carbon monoxide (CO) concentration of 2361 ppm
to meet levels previously reported for bar/restaurant environments
[21] checked via continuous measurement by a Horiba (MEXA-
311GE) CO-CO2 analyzer. The desired CO concentration was
achieved by combustion of cigarettes from various popular brands
(i.e., equal number of Camel, Davidoff Classic, Gauloises Filter,
Original Red Lucky Strike, Marlboro Reds, Prince Classic and
Silk Cut Purple King Size cigarettes). The cigarettes were lit and
placed on ashtrays to burn until reaching the filter at different
places in the chamber, while fans were used to ensure circulation
throughout the chamber. When the desired CO concentration was
attained, the participant entered the chamber.
Serum and Urine Cotinine. Serum and urine cotinine were
measured. Both serum and urine samples were obtained to ensure
validity since, although urine is the specimen of choice for SHS
(urine cotinine concentration is ,106higher than in circulation),
such samples may be subject to contamination. Whole blood
(15 ml) was collected by a certified phlebotomist from an
antecubital vein into plain evacuated test tubes and a portion of
Figure 1. Overview of the experimental protocol. In the baseline trial (TB) participants underwent a physical exertion bout that started at
1200 h without any SHS. In the remaining trials, one hour of SHS was administered at either 0800 h (T3), 1000 h (T1) or 1100 h (T0), while the same
physical exertion protocol initiated at 1200 h. SHS=secondhand smoke.
doi:10.1371/journal.pone.0031880.g001
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processing included allowing the blood to clot at room
temperature (i.e., ,23uC) for 30 min and centrifugation at
10006 g for 10 min. The serum layer was then removed and
frozen in multiple aliquots at 220uC until analyzed. For urine
cotinine analyses, 80 mL urine void was collected in polyethylene
specimen jars (Fisher Scientific, Pittsburgh) and was immediately
frozen at 220uC, until analyzed.
The serum sample preparation of cotinine biochemical analysis
included mixture of an aliquot (1 ml) of each sample with 1 ml of
buffer solution (pH=6.88). The urine sample preparation
included mixture of an aliquot (5 ml) of each sample with 2.5 ml
of buffer solution (pH=6.88). All analyses were conducted via
electron ionization mass spectrometric confirmatory analysis using
a Finnigan Mat GCQTM system equipped with an HP-5MSI
(30 m60.25 mm ID60.25 mm) capillary column (J&W Scientific).
Two microliters of each sample were injected into the system in
the splitless mode. Analysis conditions were as follows: The
column temperature program started from 90uC for 1 min and
was raised to 280uC at the rate of 20uC?min
21. The injector
temperature was 280uC. The transfer line temperature was set at
300uC. The mass spectrometer acquisition parameters were: Ion
source 200uC, electron impact ionization 70eV and electron
multiplier voltage of 1200V. The mass spectrometer was operated
at the selected ion-monitoring mode and was programmed for the
detection of m/z=84 for nicotine (cotinine) and m/z=180, 209
for ketamine. Under these conditions nicotine (cotinine) eluted at
6.16 min and ketanine at 10.15 min.
Lung Function. Forced vital capacity (FVC), forced
expiratory volume in 1 second (FEV1), FEV1/FVC ratio, peak
expiratory flow (PEF) and maximum expiratory flow when 75%,
50% and 25% of FVC remains in the lungs (MEF75%,M E F 50%,
MEF25%, respectively) were measured in a single-expiration maneuver
via spirometry. In addition, maximum voluntary ventilation,
respiratory rate, and tidal volume were measured over a 15-second
time period and data were extrapolated to 1-minute values. The lung
function assessment measurements were conducted using a hand held
spirometer (Spiromed 180, Fukuda Sangyo, Tokyo) calibrated before
each use and conformed to the American Thoracic Society
recommendations [22]. The percent of predicted FEV1 (%FEV1)w a s
also calculated based on sex- and age-specific reference values [23].
Cytokine Assessment. Levels of specific pro-inflammatory
[IL-6, TNF-a and interferon gamma (IFN-c)] and allergic-related
[IL-4 and IL-5] cytokines were assessed using 10 ml of whole
blood following blood collection and immediate sample processing
identical to that previously described for serum cotinine. Cytokine
levels were measured using commercially available enzyme-
immunosorbent assay kits (Biosource Europe S.A.) according to
the manufacturer’s protocol. The lower limits of detection were:
IL-4 and IL-5: 5 pg?mL
21, IL-6: 2 pg?mL
21, TNF-a:3p g ?mL
21,
and IFN-c:5p g ?mL
21. The reproducibility was assessed by two
consecutive measurements on the same day in samples from a
subgroup of 15 individuals. The coefficient of variation for the
assessed cytokines were: IL-4: 6.7%, IL-5: 3.8%, IL-6: 3.7%, TNF-
a: 3.6%, and IFN-c: 6.6%.
Physical Exertion Protocol and Recorded
Variables. Participants underwent a maximal oxygen uptake
protocol consisting of a 3-minute warm-up period of steady-state
cycling (Monark Ergomedic 839E, Vansbro, Sweden) at 60 W,
followed by increments of 30W?min
21 until exhaustion. Pedaling
rate was maintained at 60 revolutions?min
21 throughout. An
automated gas analyzer (Vmax 29, Sensormedics, USA) was used
to record respiratory variables every 20 sec while individuals
inspired room air. The highest oxygen uptake (ml?kg
21?min
21) for
any 20-sec interval was recorded as the individual’s maximal
oxygen uptake. The percent predicted maximal oxygen uptake
[24] and percent predicted power output [25] were calculated
based on published norms for average cardiorespiratory fitness.
During the physical exertion protocol, respiratory exchange ratio
and mean power output (in kJ) were continuously recorded, while
subjective ratings of perceived exertion (RPE) [ranging from 0 (not
hard at all) to 20 (very very hard) with increments of 1] [26] were
measured every five minutes.
Five minutes following the end of physical exertion (passive
recovery with participants lying in semi-supine position), heart rate
(Polar Electro, Kempele, Finland), arterial blood pressure, cotinine,
lung function and cytokine levels were evaluated. Blood pressure
measurements were conducted by the same trained investigator
using the same mercury sphygmomanometer (AS007, UK). The
arterial blood pressure readings were used to calculate mean arterial
pressure (i.e., diastolic+[0.333?(systolic-diastolic)]) [27].
Statistical Analysis
The data were divided by sex into groups given the known
sexual dimorphism in the acute SHS effects [6]. Sample size
calculations were conducted based on values before and after a
similar 1-hour SHS exposure for serum cotinine (61.9618.8 vs.
187.0676.3 in men and 67.5623.6 vs. 185.3666.1 in women)
and mean work done [242.4661.1 vs. 135.6641.2 in men and
159.0638.3 vs. 84.8626.6 in women) from a previous SHS
experiment in our laboratory [28] (see also correction [29]). The
resulting minimum required total sample size (two-tailed hypoth-
esis) for a statistical power level of 0.8 and a probability level of
0.05 was 10.
Given that several variables did not fulfill the assumptions of
multivariate analysis of variance, non-parametric statistical
techniques were employed. Two Kruskal-Wallis ANOVA were
computed separately for men and women to assess the effect of
time (i.e., TB, T0, T1 and T3) after SHS on all the examined
variables. These analyses were followed by sex-specific post-hoc
Mann–Whitney U tests assessing differences between time points
(i.e., TB vs. T0; T0 vs. T1; T1 vs. T3; TB vs. T1; and TB vs. T3).
Comparisons between sexes for the same time point were
conducted using Mann–Whitney U tests. The sample size
calculations were conducted with PASS 2000 (Hintze J. Number
Cruncher Statistical Systems, Kaysville, UT, USA) software, while
all other statistical analyses were carried out with PASW Statistics.
The level of significance was set at P,0.05.
Results
Sixteen healthy adults [8 men (28.364.4 years; BMI:
22.762.2 kg/m
2), 8 women (26.263.9 years; BMI: 21.361.1 kg/
m
2)] from the general population volunteered and provided
informed consentprior to participation. The subjects were generally
active individuals, but were not participating in organized sport
activities, while some of them had participated in a previous
secondhand smoke experiment by our group [28]. Results showed
that, compared to TB, there were marked differences in the majority
of the examined variables at T0 while values at T1 and – mainly – at
T3 had returned to TB levels. In men, Kruskal-Wallis ANOVA
revealed that IL-4 (P=0.002), TNF-a (P=0.002), perceived
exertion (P=0.017), recovery systolic blood pressure (P=0.012),
as well as serum (P=0.021) and urine cotinine (P,0.001) increased
whereas the FEV1/FVC (P=0.019) decreased across time. The
same analysis in women demonstrated that TNF-a (P=0.001),
perceived exertion (P=0.003), recovery systolic blood pressure
(P=0.025), recovery mean arterial pressure (P=0.039), respiratory
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cotinine increased across time. In contrast, maximal oxygen
consumption (P=0.023), percent predicted power output
(P=0.047), FEV1 (P=0.048), %FEV1 (P=0.001), FEV1/FVC
(P,0.001), MEF50% (P,0.001), MEF25% (P,0.001), maximum
voluntary ventilation (P=0.046), and tidal volume (P=0.004)
decreased across time.
Results from sex-specific post-hoc t-tests are presented in
Tables 1, 2, 3. A general trend was observed whereby marked
differences were detected between TB and T0 while values in T1
and – mainly – T3 showed a tendency towards returning to TB
levels. The majority of variables demonstrated statistically
significant results, yet some did not mainly due to increased
dispersion. Regarding performance, perceived exertion was
increased and percent predicted maximal oxygen uptake was
decreased in both sexes following SHS. In men, absolute and
relative maximum power output was decreased, and in women
maximal oxygen uptake was reduced while maximal respiratory
exchange ratio was elevated (P,0.05). The cardiovascular indices
assessed revealed increased recovery systolic and mean arterial
blood pressure following SHS in both sexes (P,0.05). Moreover,
maximum systolic and diastolic blood pressure during physical
exertion were also elevated only in women (P,0.05). The lung
function parameters measured showed that FEV1/FVC was
decreased following SHS in both sexes (P,0.05). Interestingly,
women demonstrated significant reductions (P,0.05) in all other
lung function parameters measures, with the exception of PEF.
With respect to immune function, TNF-a and IFN-c were
increased following SHS in both sexes, as well as IL-4 only in
men (P,0.05). At T3, most of the assessed variables had returned
Table 1. Mean 6 SD of cardiorespiratory variables for men and women for the statistically significant post-hoc comparisons.
TB T0 T1 T3
Max O2 uptake M 42.265.5 38.865.2 39.365.5 39.464.5
(ml?kg
21?min
21) W 39.662.3 36.361.7
a 36.561.7
b 36.863.4
% Max O2 uptake M 102.468.5 94.168.1
a, c 95.4612.6 95.8610.9
(%) W 111.968.0 102.767.5
a, c 103.367.1 104.2612.2
Max respiratory M 1.3160.06
c 1.3560.08 1.3460.07 1.3460.10
c
exchange ratio W 1.2260.06
c 1.2860.08
a 1.2760.06 1.2260.08
c
Max Power M 300.0645.4
c 251.3627.5
a, c 270.0627.8
c 285.0635.9
c
(kJ) W 224.5648.2
c 207.7636.2
c 217.0644.9
c 217.5651.0
c
%Max Power M 123.6614.2 104.2614.9
a, c 111.9614.3
c 117.5610.9
(%) W 146.1638.2 135.1630.5
c 141.6638.8
c 141.8640.9
Perceived Exertion M 17.961.1 19.161.0
a 18.960.9 19.060.9
b
W 18.260.4 19.260.3
a 19.060.9
b 19.360.3
b
Time to exhaustion M 10:3661:40 9:2360:57 9:3860:52 9:5260:47
(min:sec) W 9:5960:22 9:4760:24 9:5460:27 9:4460:25
Max HR M 185.067.7 185.467.2 185.467.0 184.964.5
(beats?min
21) W 183.466.1 184.466.4 184.565.7 184.364.4
Recovery HR M 112.4613.9 115.464.1
c 112.969.8 112.366.4
c
(beats?min
21) W 102.9615.1 108.462.7
c 106.968.3 102.966.9
c
Max SBP M 173.8610.8 184.1617.7 186.0613.7 183.4612.1
(mmHg) W 173.065.0 180.4616.4
a 182.2610.5
b 181.767.4
b
Recovery SBP M 119.366.5 131.064.8
a 132.066.7
b 129.468.4
b
(mmHg) W 126.8614.7 136.1611.9
a 137.6610.2
b 136.3611.5
b
Max DBP M 81.866.3 87.869.8 87.967.6 83.8610.1
(mmHg) W 81.265.8 90.169.0
a 89.865.3
b 86.267.9
Recovery DBP M 71.366.9 75.067.6 73.368.1 72.869.7
(mmHg) W 74.665.0 78.564.1 76.963.6 75.865.5
Max MAP M 87.264.9 93.765.0 92.866.2 91.667.1
(mmHg) W 92.066.8 97.764.9 97.165.3 95.965.6
Recovery MAP M 87.264.9 93.665.0
a 92.866.2
b 91.667.1
(mmHg) W 92.066.8 97.764.8
a 97.165.3
b 95.965.6
Note:
a=statistically significant (P,0.05) difference from previous measurement.
b=statistically significant (P,0.05) difference of T1 or T3 from TB.
c=statistically significant (P,0.05) difference between sexes for the same measurement.
Key: %Max O2 uptake: percent predicted maximal oxygen uptake; HR: heart rate; SBP, DBP, and MAP: systolic, diastolic and mean arterial blood pressure, respectively; M:
men; W: women.
doi:10.1371/journal.pone.0031880.t001
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exertion, recovery systolic blood pressure, as well as serum and
urine cotinine at T3 remained different than TB levels (P,0.05) in
both sexes. Moreover, significant differences between T3 and TB
(P,0.05) were observed for IL4 and TNF-a in men, as well as for
exercise systolic blood pressure, %FEV1, FEV1/FVC, respiratory
rate and tidal volume in women.
Discussion
Previous results by our group [5,6,7,8] in resting nonsmokers
showed that brief SHS at bar/restaurant levels attenuates lung
function for at least one hour and augments cytokine production
and carbohydrate utilization for at least three hours. In addition,
we recently showed that SHS at levels equal to those adopted
herein adversely affects the cardiorespiratory and immune
response to prolonged submaximal physical exertion for at least
three hours [28]. In the present study, we found that the
cardiorespiratory and immune systems are also compromised
when SHS is followed by brief physical exertion of maximal
intensity. These results suggest that individuals who are exposed to
SHS and then have to undergo maximal physical exertion will
under-perform, perceive the required task as more difficult, and
will be at an increased risk for cardiovascular, respiratory, or
allergic symptoms.
Despite their decline in recent decades, the prevalence of
smoking in blue-collar workers [i.e., individuals working in
farming, fishing, forestry, construction, extraction, maintenance,
production, transportation, and material moving occupations]
[30] of developed countries remains higher than that of all other
occupational groups combined [16,17,31,32]. Moreover, blue
collar workers have a higher risk for SHS at work [15,33]. These
statistics suggest that an enormous part of the population that are
physically active on a daily basis for at least 8 hours are, at the
same time, smoking passively. Indeed, blue collar workers account
for 24.7% and 25.8% of the total workforce in the United States
[30] and the European Union [34], respectively.
Based on the present results, SHS is associated with a 12%
decrease in maximum power output, an 11.5% decrease in relative
power output, an 8.2% reduction in maximal oxygen consump-
Table 2. Mean 6 SD of cotinine and lung function for men and women for the statistically significant post-hoc comparisons.
TB T0 T1 T3
Serum Cotinine M 9.464.3 22.569.9
a 34.1618.3
b 28.7620.1
b
(ng?mL
21)W 8 . 1 62.8 27.068.8
a 33.6619.3
b 28.8613.6
b
Urine Cotinine M 82.3612.6 169.2651.2
a 273.76102.7
a 262.1693.6
b
(ng?mL
21) W 74.5614.3 165.1656.6
a 249.4693.2
a, b 250.6697.8
b
FVC M 5.461.1
c 5.561.1
c 5.461.1
c 5.461.1
c
(L) W 3.760.5
c 3.760.6
c 3.860.6
c 3.660.6
c
FEV1 M5 . 1 60.7
c 4.260.8
c 4.560.8
c 4.660.7
c
(L) W 3.560.3
c 2.960.4
a, c 3.060.4
b, c 3.260.4
c
%FEV1 M 114.8612.6 98.3615.0 103.3615.5 105.3613.4
(%) W 110.164.5 93.066.8
a 95.465.8
b 102.168.4
b
FEV1/FVC M 0.9460.12 0.7960.06
a 0.8360.08
b 0.8660.09
W 0.9460.05 0.7960.03
a 0.8060.04
b 0.8960.04
a, b
PEF M 10.361.4
c 10.261.3
c 9.761.3
c 10.461.4
c
(L?sec
21)W 8 . 0 61.7
c 8.061.7
c 7.561.5
c 8.261.8
c
MEF75% M8 . 4 61.6 7.161.1
c 7.661.2
c 8.461.4
(L?sec
21)W 7 . 1 61.1 5.461.1
a, c 6.261.2
c 6.761.4
MEF50% M5 . 6 61.4 4.661.1 4.961.0
c 5.561.1
(L?sec
21)W 5 . 0 60.4 3.660.5
a 4.060.5
b, c 4.660.6
a
MEF25% M3 . 1 61.4 2.061.3 2.561.2 3.061.4
(L?sec
21)W 3 . 5 60.3 2.760.5
a 2.660.3
b 3.260.3
a
MVV M 139.0622.7
c 113.6638.2 120.3633.1 129.7625.8
(L) W 116.6618.3
c 88.0620.7
a 97.2616.0 109.4617.5
RR M 133.8641.4
c 162.3659.2 154.2659.8 154.3652.8
(#) W 101.9610.2
c 158.5611.9
a 146.2614.9
a, b 139.3619.1
b
TV M 1.1760.48 0.9860.66 0.9560.61 1.0860.56
(L) W 1.1760.22 0.8160.25
a 0.7060.14
b 0.8760.20
a, b
Note:
a=statistically significant (P,0.05) difference from previous measurement.
b=statistically significant (P,0.05) difference of T1 or T3 from TB.
c=statistically significant (P,0.05) difference between sexes for the same measurement.
Key: FVC: forced vital capacity; FEV1: forced expiratory volume in 1 second; %FEV1: percent predicted FEV1; PEF: peak expiratory flow; MEF75%,M E F 50%, MEF25%:
maximum expiratory flow when 75%, 50% and 25% of FVC remains in the lungs, respectively; MVV: maximum voluntary ventilation; RR: respiratory rate; TV: tidal
volume; M: men; W: women.
doi:10.1371/journal.pone.0031880.t002
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exhaustion, and a 9.8% increase in recovery systolic blood pressure at
T0 (Tables 1, 2, 3). It is important to also note that perceived exertion
and recovery systolic blood pressure remained elevated even when
physical exertion was administered three hours following SHS. Lung
function was markedly deteriorated when the physical task was
administered immediately following SHS and tended to return to
baseline values thereafter. Yet, %FEV1,F E V 1/FVC, respiratory rate
and tidal volume remained affected in women even three hours
followingSHS,suggestingthattheeffectsofSHSonlungfunctionare
intensified in women when maximal physical exertion is involved.
The observed SHS-induced increase in circulating inflammatory
markers extends the findings of a small number of previous human
experiments reporting SHS-induced increases of IL-1 beta, TNF-a
[6,28], white blood cell count, C-reactive protein, homocysteine,
fibrinogen [11] as well as leukocyte counts accompanied by an
activation of the immune cells [13]. The fact that IL-4, TNF-a,a n d
IFN-c remained elevated at T3 only in men supports recent
experiments by our group [6,28] showing an increased SHS-induced
inflammatory reaction in men compared to women.
The only previous experiment investigating responses to
maximal physical exertion following SHS reported prolonged
time to heart rate recovery and decreased maximal oxygen uptake
[35]. Unfortunately, this experiment incorporated very intense
SHS (i.e., 30–35 ppm CO). A recent study reported that CO
concentrations in Polish pubs can reach as high as 33 ppm, yet this
very high concentration was observed only in 4.5% of the assessed
establishments, that were characterized by very small capacious-
ness and limited ventilation [36]. Furthermore, the aforemen-
tioned study assessing responses to maximal physical exertion
following SHS presented very limited information regarding the
exercise stress and the measurements conducted. As such, it is very
difficult to derive useful conclusions based solely on the findings of
this single report. To the best of our knowledge, the present paper
presents results from the first experiment to use a standardized
experimental protocol [5,6,12,28] with SHS set at levels similar to
those of average bars/restaurants to simultaneously investigate the
effects of SHS and their duration on the cardiorespiratory and
immune response to maximal physical exertion in healthy
nonsmokers.
The observed changes in cardiopulmonary function and
inflammatory cytokines did not arise from extreme and/or
prolonged SHS. The reported cotinine levels suggest moderate
and brief SHS [37], confirming a successful simulation of a bar/
restaurant smoking environment. Further, it is not possible that the
comparatively long half-life of cotinine, the diurnal variation in
lung function and inflammatory markers, or the investigators’
expectations were reflected in our results. This is because the
adopted design enabled data collection without SHS exposure (TB)
as well as immediately following (T0), at one hour after (T1) and at
three hours following SHS (T3), with the data being collected at
the same time of the day and without the effect of previous or
subsequent measurements since only one assessment was conduct-
ed per trial. Yet, our lung function results are limited by the
impossibility of blinding our participants to SHS. However,
suggestibility does not appear to underlie acute physiological
responses to SHS [38]. Moreover, the present SHS-induced
inflammatory reaction observed at T0 was similar to a previous
study by our group that incorporated a repeated-measures
randomized-block design with a sham SHS exposure [5],
providing support to our protocol.
In conclusion, our randomized crossover experiment revealed
that one hour of SHS at levels similar to those of bars/restaurants
adversely affects the cardiorespiratory and immune response to
maximal physical exertion in young healthy nonsmokers for at
least three hours following SHS exposure.
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